Squarepoint’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-71,176
| Closed | -$1.8M | – | 4675 |
|
|
2024
Q4 | $1.8M | Sell |
71,176
-2,834
| -4% | -$77K | ﹤0.01% | 2523 |
|
|
2024
Q3 | $2.52M | Sell |
74,010
-88,997
| -55% | -$3.39M | ﹤0.01% | 1913 |
|
|
2024
Q2 | $6.03M | Buy |
163,007
+54,517
| +50% | +$2.06M | 0.01% | 1244 |
|
|
2024
Q1 | $4.55M | Buy |
108,490
+90,936
| +518% | +$3.73M | 0.01% | 1512 |
|
|
2023
Q4 | $696K | Buy |
+17,554
| New | +$516K | ﹤0.01% | 2773 |
|
|
2023
Q3 | – | Sell |
-11,719
| Closed | -$398K | – | 3839 |
|
|
2023
Q2 | $398K | Buy |
+11,719
| New | +$395K | ﹤0.01% | 2780 |
|
|
2023
Q1 | – | Sell |
-6,458
| Closed | -$288K | – | 3296 |
|
|
2022
Q4 | $288K | Buy |
+6,458
| New | +$231K | ﹤0.01% | 2599 |
|
|
2022
Q3 | – | Sell |
-78,345
| Closed | -$2.11M | – | 3037 |
|
|
2022
Q2 | $2.11M | Buy |
+78,345
| New | +$2.28M | 0.01% | 1149 |
|
|
2022
Q1 | – | Sell |
-20,604
| Closed | -$796K | – | 2901 |
|
|
2021
Q4 | $796K | Buy |
20,604
+10,605
| +106% | +$462K | ﹤0.01% | 1841 |
|
|
2021
Q3 | $540K | Buy |
+9,999
| New | +$469K | ﹤0.01% | 1906 |
|
|
2021
Q2 | – | Sell |
-44,995
| Closed | -$927K | – | 3277 |
|
|
2021
Q1 | $927K | Sell |
44,995
-69,769
| -61% | -$1.6M | 0.01% | 1570 |
|
|
2020
Q4 | $2.01M | Buy |
114,764
+81,382
| +244% | +$1.46M | 0.02% | 937 |
|
|
2020
Q3 | $495K | Buy |
+33,382
| New | +$391K | 0.01% | 1442 |
|
|
2019
Q2 | – | Sell |
-12,130
| Closed | -$60K | – | 2404 |
|
|
2019
Q1 | $60K | Buy |
12,130
+8,052
| +197% | +$42.4K | ﹤0.01% | 2069 |
|
|
2018
Q4 | $12K | Sell |
4,078
-12,926
| -76% | -$63.5K | ﹤0.01% | 1883 |
|
|
2018
Q3 | $115K | Buy |
17,004
+7,421
| +77% | +$52K | ﹤0.01% | 1873 |
|
|
2018
Q2 | $72K | Buy |
+9,583
| New | +$128K | ﹤0.01% | 1671 |
|
|
2018
Q1 | – | Sell |
-2,007
| Closed | -$85K | – | 1739 |
|
|
2017
Q4 | $85K | Sell |
2,007
-477
| -19% | -$20.4K | ﹤0.01% | 1978 |
|
|
2017
Q3 | $107K | Buy |
+2,484
| New | +$93.1K | ﹤0.01% | 1503 |
|
|
2017
Q1 | – | Sell |
-3,697
| Closed | -$196K | – | 1562 |
|
|
2016
Q4 | $196K | Sell |
3,697
-4,503
| -55% | -$256K | 0.01% | 1447 |
|
|
2016
Q3 | $497K | Buy |
8,200
+7,487
| +1,050% | +$466K | 0.03% | 564 |
|
|
2016
Q2 | $47K | Sell |
713
-4,447
| -86% | -$282K | ﹤0.01% | 1031 |
|
|
2016
Q1 | $293K | Buy |
+5,160
| New | +$581K | 0.02% | 838 |
|
Other funds holding CLDX
KCM
EAM
CC
BG
